ECIR Group Inc. 2021 NO Laminitis! Conference Recorded Videos Now Available

“I am well over half way with watching everything but I take quite a bit of time as I keep pausing to make notes. To be able to get such first-hand information from the real experts has been amazing and it is knowledge that I will carry with me for the rest of my life and my horses, and my friends’ horses, will all benefit.”

Since 1999, the ECIR Group has improved the welfare of equines with metabolic disorder by focusing on prevention and treatment of endocrinopathic laminitis. Helping caregivers learn to recognize the importance of diagnosis, diet, trim, and exercise has seen thousands through the complications of Equine Cushing’s Disease and Insulin Resistance.

To this end, we are very happy to announce that the ECIR Group Inc. 2021 NO Laminitis! Conference recorded lecture videos are now available.

www.nolaminitis.org

 Bridging Research and Real Life Across the World

Speakers:     

  • Eleanor M. Kellon, VMD
  • Robert M. Bowker, VMD, PhD
  • Kathleen Gustafson, PhD
  • Elaine Norton, DVM, MS, PhD, DACVIM-LA               
  • Shannon Pratt-Phillips, MS, PhD, PAS
  • Paige Poss, APF, Anatomy of the Equine, LLC
  • Pete Ramey, PHCP Practitioner/Clinician

Who should watch these videos: Any professional or owner who has one or more horses in their care.

Subscription Pricing:  $280         

Conference Topics:

  • EMS – What It’s Not.
  • Protein and Iron — Their Affect in EMS and PPID Horses. 
  • Pros and Cons of Forage Analysis and Targeted Supplementation.
  • The Effect of Exercise on Glucose Metabolism and Insulin Sensitivity in the Horse.
  • Strategies for Using Exercise as Part of Dietary Management for Overweight and/or Insulin Resistant Horses.
  • Common EMS and PPID Pharmaceuticals.
  • Emerging EMS and PPID Pharmaceuticals. 
  • The Genetics of EMS.
  • The Impact of Genetics on Height and Insulin Dysregulation in Welsh Ponies.
  • Take it with a Grain of Salt – Navigating Nutritional Fact and Fiction.
  • Reading the Foot – Thinking Vertically.
  • Reversing Hoof Capsule Rotation and Distal Descent.
  • Looking Internally at Distal Descent and Rotation in the Hoof.
  • Estimating Palmar Angle when Looking at the Hoof.
  • What is a Normal Foot? Questions Need to be Asked.
  • Trimming Practices Can Encourage Decline in Overall Foot Health.
  • Winter Laminitis: Why the normal trim can make an episode worse.
  • How Trimming Can Improve Foot Structure and Function.

NOTE: Recordings with 20+ hours of information will be available to subscribers for six months from purchase at a private link. Subscription opportunity ends 12.31.21.

Subscribe here www.nolaminitis.org

About ECIR Group Inc.
Started in 1999, the ECIR Group is the largest field-trial database for PPID and EMS in the world and provides the latest research, diagnosis, and treatment information, in addition to dietary recommendations for horses with these conditions. Even universities do not and cannot compile and follow long term as many in-depth case histories of PPID/EMS  horses as the ECIR Group.

In 2013 the Equine Cushing’s and Insulin Resistance Group Inc., an Arizona nonprofit corporation, was approved as a 501(c)3 public charity. Tax deductible contributions and grants support ongoing research, education, and awareness of Equine Cushing’s Disease/PPID and EMS.

THE MISSION of the ECIR Group Inc. is to improve the welfare of equines with metabolic disorders via a unique interface between basic research and real-life clinical experience. Prevention of laminitis is the ultimate goal. The ECIR Group serves the scientific community, practicing clinicians, and owners by focusing on investigations most likely to quickly, immediately, and significantly benefit the welfare of the horse.

Contact:  Nancy Collins
603-323-7469
ecirgroup1@gmail.com
Stock photo available

 

AHP has not verified the factual statements in any message and AHP assumes no responsibility for the contents of, or any damage resulting from, any communication in the Newsgroup. Publication in the Newsgroup is not an endorsement by the organization of any product, person, or policy.